NCT03551067 is a Phase 4 clinical trial of Dexmedetomidine in Adenotonsillectomy, sponsored by Suez Canal University.

Who is sponsoring NCT03551067?

NCT03551067 is sponsored by Suez Canal University.

What drugs are being tested in NCT03551067?

Interventions in NCT03551067: Dexmedetomidine, Midazolam/Ketamine.

What condition does NCT03551067 study?

NCT03551067 studies Adenotonsillectomy.

Is NCT03551067 still recruiting?

NCT03551067 is currently completed. Last updated 5 July 2018.

Last reviewed 2018-07-05 · How we verify

NCT03551067

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oral Dexmedetomidine for Parental Separation in Pediatrics Undergoing Adenotonsillectomy

Completed Phase 4 Last updated 5 July 2018

What this trial tests

Phase 4 trial testing Dexmedetomidine in Adenotonsillectomy in 74 participants. Completed in 5 January 2018.

Timeline

1 August 2016

Primary endpoint
15 December 2017

5 January 2018

Quick facts

Lead sponsor	Suez Canal University
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	74
Start date	1 August 2016
Primary completion	15 December 2017
Estimated completion	5 January 2018
Sites	1 location across Egypt

Drugs / interventions tested

Dexmedetomidine (dexmedetomidine) — full drug profile →
Midazolam/Ketamine

Conditions studied

Adenotonsillectomy — all drugs for Adenotonsillectomy →

Sponsor

Suez Canal University

Who can join

Adults 1 to 5, any sex, with Adenotonsillectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The efficacy of oral dexmedetomidine as sedative versus a combination of oral midazolam plus oral ketamine were compared regarding to satisfactory separation from parents, satisfactory mask induction and postoperative rescue analgesia in Pediatrics undergone Adenotosillectomy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dexmedetomidine

Trials testing the same drug.

NCT06824077 — Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle · EARLY_PHASE1 · not yet recruiting
NCT07398066 — DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial) · NA · not yet recruiting
NCT07377981 — An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyp · Phase 4 · not yet recruiting
NCT07306702 — Dexmedetomidine-Enhanced PCIA After Lobectomy in Nicotine-Dependent Patients · Phase 4 · withdrawn
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting

Other recruiting trials for Adenotonsillectomy

Currently open trials in the same condition.

NCT07345715 — Oral Melatonin Versus Nebulized Dexmedetomidine on Emergence Agitation in Children Undergoing Adenotonsillectomy · NA · recruiting
NCT06882980 — Comparison of Ciprofol and Propofol Under IoC1 and IoC2 Monitoring for Adenotonsillectomy · NA · recruiting
NCT07305168 — A Multicenter Retrospective Analysis of Postoperative Respiratory Complications in Children With Obstructive Sleepapnea · recruiting

Other Suez Canal University trials

Trials by the same sponsor.

NCT07263893 — Inter Flex Three Dimensional Plate in Management of Mandibular Fracture RCT · NA · recruiting
NCT07280533 — Accuracy of Virtual Surgical Planning Versus Traditional Technique in Zygomaticomaxillary Fracture Reduction · NA · not yet recruiting
NCT07291791 — tDCS for Pain Modulation in Knee Osteoarthritis · NA · active not recruiting
NCT07262086 — Clinical Evaluation of Wear Resistance and Bioactivity of Self Cured Bioactive Resin Composite · NA · enrolling by invitation
NCT07125846 — Efficacy of Bioactive Glass vs. Xenograft in Maxillary Sinus Augmentation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03551067 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Suez Canal University
Last refreshed: 5 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03551067.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing